Detalhe da pesquisa
1.
Long-term efficacy and safety in patients with rheumatoid arthritis continuing on SB4 or switching from reference etanercept to SB4.
Ann Rheum Dis
; 2017 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28794078
2.
A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy.
Ann Rheum Dis
; 76(1): 51-57, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26150601
3.
52-week results of the phase 3 randomized study comparing SB4 with reference etanercept in patients with active rheumatoid arthritis.
Rheumatology (Oxford)
; 56(12): 2093-2101, 2017 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28968793